| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $15.2M | +28.4% |
| SG&A Expense | $7.5M | -23.0% |
| Interest Expense | $30K | +0.0% |
| Net Income | -$22.7M | +40.8% |
| EPS (Basic) | -$0.52 | +67.5% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.8M | +11.8% |
| Current Assets | $13.3M | +12.4% |
| Total Assets | $15.9M | +17.8% |
| Current Liabilities | $4.0M | +43.5% |
| Total Liabilities | $4.2M | +40.2% |
| Stockholders' Equity | $11.8M | +11.5% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | -8.1% |
| Investing Cash Flow | $964K | +0.0% |
| Financing Cash Flow | $21.6M | -16.9% |